CN101194945A - 一种治疗头痛的片剂及其制备方法 - Google Patents
一种治疗头痛的片剂及其制备方法 Download PDFInfo
- Publication number
- CN101194945A CN101194945A CNA2006101299571A CN200610129957A CN101194945A CN 101194945 A CN101194945 A CN 101194945A CN A2006101299571 A CNA2006101299571 A CN A2006101299571A CN 200610129957 A CN200610129957 A CN 200610129957A CN 101194945 A CN101194945 A CN 101194945A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- tablet
- medicine
- starch
- headache
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010019233 Headaches Diseases 0.000 title claims abstract description 28
- 231100000869 headache Toxicity 0.000 title claims abstract description 28
- 241000218176 Corydalis Species 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims description 46
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 45
- 229920002472 Starch Polymers 0.000 claims description 33
- 239000008107 starch Substances 0.000 claims description 33
- 235000019698 starch Nutrition 0.000 claims description 33
- 239000003826 tablet Substances 0.000 claims description 29
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 17
- 241000217407 Margaritifera Species 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 14
- 239000011734 sodium Substances 0.000 claims description 14
- 239000002671 adjuvant Substances 0.000 claims description 12
- 239000011230 binding agent Substances 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000000945 filler Substances 0.000 claims description 12
- 239000008187 granular material Substances 0.000 claims description 11
- 235000019359 magnesium stearate Nutrition 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 10
- 239000000314 lubricant Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 239000004677 Nylon Substances 0.000 claims description 6
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 6
- 229920001778 nylon Polymers 0.000 claims description 6
- 229920000881 Modified starch Polymers 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 206010013786 Dry skin Diseases 0.000 claims description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 229940046011 buccal tablet Drugs 0.000 claims description 3
- 239000007891 compressed tablet Substances 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000006190 sub-lingual tablet Substances 0.000 claims description 2
- 229940098466 sublingual tablet Drugs 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 14
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- 229940095559 cafergot Drugs 0.000 description 2
- CJMJLDQKTOJACI-SEUSHGJOSA-N chembl2448612 Chemical compound OC(=O)C(O)C(O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-SEUSHGJOSA-N 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101299571A CN101194945B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101299571A CN101194945B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的片剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101194945A true CN101194945A (zh) | 2008-06-11 |
CN101194945B CN101194945B (zh) | 2013-06-05 |
Family
ID=39545691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101299571A Active CN101194945B (zh) | 2006-12-08 | 2006-12-08 | 一种治疗头痛的片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101194945B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940762A (zh) * | 2012-11-15 | 2013-02-27 | 刘永俊 | 一种治疗痛风性关节炎的中药 |
CN103877245A (zh) * | 2012-12-21 | 2014-06-25 | 天士力制药集团股份有限公司 | 一种治疗头痛的药物组合物 |
CN105902650A (zh) * | 2016-06-24 | 2016-08-31 | 中国人民解放军第三〇七医院 | 清脑片及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1047938C (zh) * | 1992-11-14 | 2000-01-05 | 中国人民解放军第二五四医院 | 一种治疗头痛的中药 |
CN1500513A (zh) * | 2002-11-15 | 2004-06-02 | 梅宗汉 | 治疗头痛的中药冲剂 |
CN1318020C (zh) * | 2004-06-25 | 2007-05-30 | 广东天之骄生命科技有限公司<Del/> | 一种养血清脑口腔崩解片及其制备方法 |
-
2006
- 2006-12-08 CN CN2006101299571A patent/CN101194945B/zh active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102940762A (zh) * | 2012-11-15 | 2013-02-27 | 刘永俊 | 一种治疗痛风性关节炎的中药 |
CN102940762B (zh) * | 2012-11-15 | 2014-01-22 | 刘永俊 | 一种治疗痛风性关节炎的中药 |
CN103877245A (zh) * | 2012-12-21 | 2014-06-25 | 天士力制药集团股份有限公司 | 一种治疗头痛的药物组合物 |
CN105902650A (zh) * | 2016-06-24 | 2016-08-31 | 中国人民解放军第三〇七医院 | 清脑片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101194945B (zh) | 2013-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101987122B (zh) | 一种用于缓解人体疼痛的药物及其制备方法 | |
CN102225138B (zh) | 一种用于治疗骨折的中药组合物及其制备方法和应用 | |
CN103830632A (zh) | 一种根治银屑病等多种皮肤病的中药制剂及其制备方法与应用 | |
CN1765392A (zh) | 一种补血调经,止血安胎的中药复方制剂及其制备方法 | |
CN101485853A (zh) | 一种活血化瘀药 | |
CN1872217B (zh) | 一种治疗头痛的药物及其制备方法 | |
CN1977959A (zh) | 一种综合调理人体机能的中药复方制剂及其制备方法 | |
CN101194945B (zh) | 一种治疗头痛的片剂及其制备方法 | |
CN101045152A (zh) | 一种治疗慢性***伴炎性包块的中药组合物 | |
CN1742919A (zh) | 一种舒尔经中药制剂及其制备方法 | |
CN1839981A (zh) | 抗妇炎分散片及制备方法 | |
CN1785391A (zh) | 一种中药组合物及其制备方法 | |
CN102416126A (zh) | 一种治疗***的中药组合剂及其制备方法 | |
CN102940844B (zh) | 一种治疗消化不良的药物组合物 | |
CN1600356A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN101502609A (zh) | 一种凉血祛瘀中药制剂 | |
CN101194959B (zh) | 一种治疗头痛的胶囊及其制备方法 | |
CN1943756A (zh) | 一种治疗高血压的中药组合物及其制备方法 | |
CN101194965B (zh) | 一种治疗头痛的咀嚼片及其制备方法 | |
CN101194966B (zh) | 一种治疗头痛的***片及其制备方法 | |
CN101987188B (zh) | 一种用于预防和治疗高血脂症的生物中成药 | |
CN101194963B (zh) | 一种治疗头痛的药物的制备方法 | |
CN101279070A (zh) | 一种温肾活血、通经活络的药物组合及其制备方法 | |
CN101194958B (zh) | 一种治疗头痛的煎膏剂的制备方法 | |
CN1247221C (zh) | 厚朴和蛇床子超临界二氧化碳提取物的复方制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent for invention or patent application | ||
CB02 | Change of applicant information |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Applicant after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Applicant before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: TIANJIN TASLY PHARMACEUTICAL CO., LTD. TO: TASLY PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |